ArticleJTCVS techniques2026
Posterior aortoventricular enlargement of root and outflow tract: Early and mid-term results.
Article in JTCVS techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Commentary: Dura lex sed lex, or when posterior is not so posterior.JTCVS techniques · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Congenital hypoplasia of the left ventricular outflow tract (LVOT) and aortic annulus is a challenging problem. We have developed a novel posterior enlargement technique that avoids a septal and right ventricular incision while effectively enlarging the LVOT and aortic annulus. Here we report mid-term results with the use of this technique. Methods: Between 2011 and 2023, 5 patients (3 males [60%]; mean age, 28 ± 23 years) underwent posterior aortoventricular enlargement. The aortic valve and root were replaced by an autograft (n = 4) or a stentless porcine prosthesis (n = 1). Results: There were cases of no early death, myocardial infarction, neurologic complications, or permanent pacemaker implantation. One patient died 3 years postoperatively in a traffic accident, and 1 patient required pulmonary conduit reoperation for infective endocarditis 6.5 years postoperatively. Freedom from cardiac death and aortic valve or root reoperation was 100% at 10 years. Two patients had AR 1 at discharge, and 3 patients had AR 1 at last follow-up, between 12.1 and 13.4 years postoperatively, including the 2 with AR 1 at discharge. Median LVOT diameter was 12 mm preoperatively (interquartile range [IQR], 9.5-12.6 mm), 20 mm (IQR, 20-21 mm) at discharge, and 20 mm (IQR, 20-21 mm) at last follow-up. Median annular diameter was 17 mm (IQR, 15-18 mm) preoperatively, 21 mm (IQR, 20-22 mm) at discharge, and 25 mm (IQR, 24-26 mm) at last follow-up. Median LVOT gradient was reduced from 50 mm Hg (IQR 41-57 mm Hg) preoperatively to 9 mm Hg (IQR, 7-16 mm Hg) at discharge. All patients remained in sinus rhythm with normal PR intervals and QRS complexes. Conclusions: Posterior aortoventricular enlargement combined with root replacement yields effective relief of LVOT and annular hypoplasia. It appears to be a durable option for younger and older patients alike.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.